GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter LlpImmunityBio Faces Securities Fraud Suit Over FDA Warning on Cancer Drug Claims
ImmunityBio faces securities fraud lawsuit after FDA warning over misleading cancer drug claims by Executive Chairman Soon-Shiong, triggering 21.12% stock decline.
IBRXsecurities fraudclass action lawsuit